Cargando…
Telehealth and 30-Day Readmissions Among Heart Failure Patients During the COVID-19 Pandemic
This study examined whether outpatient follow-up within 14 days of discharge via telehealth visits are as effective as in-person visits for reducing 30-day readmission in heart failure (HF) patients. Using electronic health records from a large health system, we included HF patients (n=1,722) who we...
Autores principales: | Xu, Hanzhang, Granger, Bradi, Peterson, Eric, Dupre, Matthew |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8970218/ http://dx.doi.org/10.1093/geroni/igab046.1801 |
Ejemplares similares
-
Effectiveness of Telemedicine Visits in Reducing 30‐Day Readmissions Among Patients With Heart Failure During the COVID‐19 Pandemic
por: Xu, Hanzhang, et al.
Publicado: (2022) -
30-DAY READMISSION IN PATIENTS WITH CARDIOVASCULAR DISEASE: DO PATIENTS KNOW THEIR RISK BEFORE DISCHARGE?
por: Xu, Hanzhang, et al.
Publicado: (2019) -
Understanding Barriers to Healthcare Access for Heart Failure Patients during the COVID-19 Pandemic
por: Xu, Hanzhang, et al.
Publicado: (2021) -
Identifying Nonclinical Factors Associated With 30-Day Readmission in Patients with Cardiovascular Disease: Protocol for an Observational Study
por: Dupre, Matthew E, et al.
Publicado: (2017) -
Factors associated with racial differences in all-cause 30-day readmission in adults with cardiovascular disease: an observational study of a large healthcare system
por: Farmer, Heather R, et al.
Publicado: (2022)